1.
Li B, Wang Y, Ye Z, Yang H, Cui X, Wang Z, et al. Effects of Canagliflozin on Fatty Liver Indexes in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials. J Pharm Pharm Sci [Internet]. 2018 Jun. 24 [cited 2024 Nov. 30];21(1):222-35. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/29831